SCHEMBL7873301

SCHEMBL7873301

N=C(N)N(Cc1ccc([N+](=O)[O-])cc1)C(=O)c1cc2ccccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.45
PDGFRA P16234 1/20 0.45
AR P10275 1/20 0.43
DRD3 P35462 1/20 0.43
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
MAPT P10636 3/20 0.40
IDO1 P14902 2/20 0.40
GLA P06280 1/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
FLT3 P36888 1/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7873549 0.99 PDGFRB (0.45) PDGFRBPDGFRAARDRD3CRHBP
SCHEMBL7873563 0.86 AR (0.56) ARKDM4EALDH1A1GAAMAPK1
SCHEMBL8627247 0.85 AR (0.47) ARKDM4EALDH1A1GAAMAPK1
Hydrochloric Acid SCHEMBL7877804 0.85 AR (0.55) ARKDM4EALDH1A1GAAMAPK1
Hydrochloric Acid SCHEMBL7882303 0.84 AR (0.47) ARKDM4EALDH1A1GAAMAPK1
Hydrochloric Acid SCHEMBL7882110 0.84 AR (0.46) ARKDM4EALDH1A1GAAMAPK1
Hydrochloric Acid SCHEMBL7881242 0.82 KDM4E (0.45) PDGFRBPDGFRAARKDM4EALDH1A1
Hydrochloric Acid SCHEMBL7880907 0.81 MEN1 (0.54) PDGFRBPDGFRADRD3KDM4EALDH1A1
SCHEMBL7882001 0.76 KDM4E (0.50) PDGFRBPDGFRAARKDM4EALDH1A1
SCHEMBL7881252 0.76 KDM4E (0.51) PDGFRBPDGFRAKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed